SFRP2 and hypertensive disorder: We used SHRs aged 8, 12, and 20 weeks to demonstratethe progress from pre-HTN to established HTN, which also compensated forhypertrophy [22], and found that the temporal increase in cardiac sFRP2 wassimilar to the morphological changes.